• OVPR

    The Office of the Vice President for Research facilitates collaborative research opportunities, streamlines related policies and procedures, and acts as a unified voice for U of I research.

  • UIC OTM

    The Office of Technology Management at Chicago is responsible for managing the intellectual property generated by research and educational activities at the University.

  • UIC Research Center

    Supplies a fully-equipped infrastructure and access to University resources, internship programs, world-class talent, and custom-designed business development services.

  • UI Research Park

    Provides an ideal environment for starting a high-growth technology venture, with wet-chemistry labs, office space, an array of shared equipment, server co-location facilities, and conference rooms.

  • IllinoisVENTURES

    IllinoisVENTURES is a seed and early-stage technology investment firm focused on research-derived companies in information technologies, physical sciences and life sciences, with a particular emphasis on those deriving from research conducted at the University of Illinois and other regional research institutions and federal laboratories.

Office of Technology Management, Urbana-Champaign

Technologies

Other Categories

  • Energy/Environment
  • Energy Active
  • Energy Passive
  • Engineering
  • Electronics
  • Optics
  • Life Sciences Non-Health
  • Greater Good
  • Software

Angiogenesis

Nexturastat, a novel Urea-based HDAC6 inhibitor effective against specific cancers
Histone deacetylases (HDACs) mediate regulation of gene expression via changes in nucleosome conformation.  Dysregulation of histone acetylation, can lead to the development of cancers. There is renewed interest in capitalizing new breakthroughs in epigenetic research to address oncology therapy. Epigenetic regulation and subsequent gene expression or silencing represents a tightly orchestrated interplay among enzymes responsible for modifying the tails of histones, around which nuclear DNA is wrapped.
Chicago, Circulatory, Oncologic, Angiogenesis
Therapeutic Scheme for Human Basigin
Cancer researchers are focusing their efforts on identifying central pathways that trigger or enhance the invasiveness of tumor cells. One such target is EMMPRIN (Extracellular Matrix Metalloproteinase Inducer). It has been shown that EMMPRIN expression is linked to various cell signaling pathways that lead to an increase in tumor cell vascularization. Researchers are focusing efforts on elucidating the role of EMMPRIN in a number of disorders including cancer, arthritis, tissue repair and numerous inflammation-dependent diseases. 
ALL OF THESE, ALL OF THESE, Urbana-Champaign, Angiogenesis, Angiogenesis, Therapeutic
print